Genmab reported DKK2.99B in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Amarin AMRN:US USD 287.36M 74.22M
Amgen AMGN:US USD 15.69B 1.36B
Artemis Alpha ATS:LN GBP 5.37M 25K
AstraZeneca AZN:LN USD 24.85B 3.04B
Bayer BAYN:GR EUR 33.17B 471M
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Exelixis EXEL:US USD 301.73M 2.79M
Fresenius Medical Care FME:GR EUR 6.36B 519.61M
Galapagos GLPG:NA EUR 532.21M 18.52M
Genmab GEN:DC DKK 2.99B 1.04B
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
GN Store Nord GN:DC DKK 10.89B 987M
Hikma Pharmaceutical HIK:LN USD 1.01B 6M
Immunogen IMGN:US USD 103.64M 16.57M
Insmed INSM:US USD 137.65M 23.84M
Lonza Group LONN:SW CHF 3.08B 454M
Merck MRK:GR EUR 9.41B 306M
Novartis NOVN:VX USD 28.16B 514M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Roche Holding ROG:VX 27.41B 11.01B
Seattle Genetics SGEN:US USD 726M 117.48M
William Demant Holding WDH:DC DKK 12.72B 1.75B